ZA200110205B - IL-8 receptor antagonists. - Google Patents

IL-8 receptor antagonists.

Info

Publication number: ZA200110205B
Authority: ZA; South Africa
Prior art keywords: receptor antagonists; antagonists; receptor
Prior art date: 1999-06-16

Application number

ZA200110205A

Inventor

Katherine L Widdowson

Benson Gregory Martin

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-16

Filing date

2000-12-12

Publication date

2002-08-12

2000-12-12 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2002-08-12 Publication of ZA200110205B publication Critical patent/ZA200110205B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biotechnology (AREA)
Diabetes (AREA)
Hematology (AREA)
Psychiatry (AREA)
Immunology (AREA)
Dermatology (AREA)
Surgery (AREA)
Hospice & Palliative Care (AREA)

ZA200110205A 1999-06-16 2000-12-12 IL-8 receptor antagonists. ZA200110205B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US13967399P	1999-06-16	1999-06-16

Publications (1)

Publication Number	Publication Date
ZA200110205B true ZA200110205B (en)	2002-08-12

Family

ID=22487779

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200110205A ZA200110205B (en)	1999-06-16	2000-12-12	IL-8 receptor antagonists.

Country Status (20)

Country	Link
EP (1)	EP1185271A4 (en)
JP (1)	JP2003501470A (en)
KR (1)	KR20020012275A (en)
CN (1)	CN1356902A (en)
AR (1)	AR024349A1 (en)
AU (1)	AU767000B2 (en)
BR (1)	BR0011567A (en)
CA (1)	CA2377391A1 (en)
CO (1)	CO5190709A1 (en)
CZ (1)	CZ20014491A3 (en)
HU (1)	HUP0202004A3 (en)
IL (1)	IL146515A0 (en)
MX (1)	MXPA01013089A (en)
NO (1)	NO20016102L (en)
NZ (1)	NZ515609A (en)
PL (1)	PL352222A1 (en)
TR (1)	TR200103608T2 (en)
UY (1)	UY26206A1 (en)
WO (1)	WO2000076515A1 (en)
ZA (1)	ZA200110205B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0704651D0 (en) *	2007-03-09	2007-04-18	Ucl Business Plc	Composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2060682T3 (en) *	1988-03-30	1994-12-01	Warner Lambert Co	N - ((FENIL (2,6-DISUBSTITUTED)) - N'-ARIL) UREAS AS ANTI-HYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS.
US5780483A (en) *	1995-02-17	1998-07-14	Smithkline Beecham Corporation	IL-8 receptor antagonists
CA2294064A1 (en) *	1997-07-29	1999-02-11	Smithkline Beecham Corporation	Il-8 receptor antagonists

2000
- 2000-06-13 UY UY26206A patent/UY26206A1/en not_active Application Discontinuation
- 2000-06-14 AR ARP000102921A patent/AR024349A1/en not_active Application Discontinuation
- 2000-06-14 CO CO00044227A patent/CO5190709A1/en not_active Application Discontinuation
- 2000-06-15 BR BR0011567-3A patent/BR0011567A/en not_active IP Right Cessation
- 2000-06-15 NZ NZ515609A patent/NZ515609A/en unknown
- 2000-06-15 PL PL00352222A patent/PL352222A1/en not_active Application Discontinuation
- 2000-06-15 AU AU58750/00A patent/AU767000B2/en not_active Ceased
- 2000-06-15 CZ CZ20014491A patent/CZ20014491A3/en unknown
- 2000-06-15 MX MXPA01013089A patent/MXPA01013089A/en unknown
- 2000-06-15 CN CN00809095A patent/CN1356902A/en active Pending
- 2000-06-15 JP JP2001502848A patent/JP2003501470A/en not_active Withdrawn
- 2000-06-15 EP EP00944689A patent/EP1185271A4/en not_active Withdrawn
- 2000-06-15 WO PCT/US2000/016510 patent/WO2000076515A1/en not_active Ceased
- 2000-06-15 IL IL14651500A patent/IL146515A0/en unknown
- 2000-06-15 HU HU0202004A patent/HUP0202004A3/en unknown
- 2000-06-15 TR TR2001/03608T patent/TR200103608T2/en unknown
- 2000-06-15 CA CA002377391A patent/CA2377391A1/en not_active Abandoned
- 2000-06-15 KR KR1020017016141A patent/KR20020012275A/en not_active Withdrawn
- 2000-12-12 ZA ZA200110205A patent/ZA200110205B/en unknown
2001
- 2001-12-14 NO NO20016102A patent/NO20016102L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2377391A1 (en)	2000-12-21
JP2003501470A (en)	2003-01-14
CN1356902A (en)	2002-07-03
HUP0202004A3 (en)	2003-03-28
TR200103608T2 (en)	2002-06-21
MXPA01013089A (en)	2002-06-04
IL146515A0 (en)	2002-07-25
AU5875000A (en)	2001-01-02
CZ20014491A3 (en)	2002-07-17
HUP0202004A2 (en)	2002-10-28
NO20016102L (en)	2002-02-12
AR024349A1 (en)	2002-10-02
EP1185271A4 (en)	2004-02-04
PL352222A1 (en)	2003-08-11
UY26206A1 (en)	2000-12-29
KR20020012275A (en)	2002-02-15
BR0011567A (en)	2002-03-05
NZ515609A (en)	2003-11-28
AU767000B2 (en)	2003-10-30
CO5190709A1 (en)	2002-08-29
EP1185271A1 (en)	2002-03-13
NO20016102D0 (en)	2001-12-14
WO2000076515A1 (en)	2000-12-21

Publication	Publication Date	Title
EP1284956A4 (en)	2005-08-24	Il-8 receptor antagonists
IL145761A0 (en)	2002-07-25	Il-8 receptor antagonists
DZ3309A1 (en)	2001-09-07	Il-8 receptor antagonists
AU4560601A (en)	2001-09-24	Il-8 receptor antagonists
IL145762A0 (en)	2002-07-25	Il-8 receptor antagonists
EP1274415A4 (en)	2005-09-07	Il-8 receptor antagonists
PL351946A1 (en)	2003-07-14	Il-8 receptor antagonists
AP2002002599A0 (en)	2002-09-30	Il-8 receptor antagonists
EP1265905A4 (en)	2003-03-12	Il-8 receptor antagonists
ZA200109627B (en)	2002-11-28	IL-8 receptor antagonists.
EP1274413A4 (en)	2005-08-10	Il-8 receptor antagonists
ZA200201780B (en)	2003-05-28	Vitronectin receptor antagonists.
EP1274428A4 (en)	2003-05-02	Il-8 receptor antagonists
EP1263427A4 (en)	2005-08-24	Il-8 receptor antagonists
EP1194143A4 (en)	2004-02-04	Il-8 receptor antagonists
EP1261329A4 (en)	2005-08-17	Il-8 receptor antagonists
EP1185270A4 (en)	2004-02-11	Il-8 receptor antagonists
AU5168900A (en)	2000-12-18	Il-8 receptor antagonists
ZA200110205B (en)	2002-08-12	IL-8 receptor antagonists.
ZA200110203B (en)	2002-09-11	IL-8 receptor antagonists.
EP1265603A4 (en)	2005-09-28	Il-8 receptor antagonists
AU5622400A (en)	2001-01-02	Il-8 receptor antagonists
EP1237548A4 (en)	2003-07-23	Il-8 receptor antagonists
HK1044473A (en)	2002-10-25	Il-8 receptor antagonists
HK1044474A (en)	2002-10-25	Il-8 receptor antagonists